Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2013 1
2014 1
2015 3
2016 3
2017 3
2018 3
2019 7
2020 8
2021 27
2022 25
2023 17
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review.
Papp V, Magyari M, Aktas O, Berger T, Broadley SA, Cabre P, Jacob A, Kira JI, Leite MI, Marignier R, Miyamoto K, Palace J, Saiz A, Sepulveda M, Sveinsson O, Illes Z. Papp V, et al. Neurology. 2021 Jan 12;96(2):59-77. doi: 10.1212/WNL.0000000000011153. Epub 2020 Dec 11. Neurology. 2021. PMID: 33310876 Free PMC article.
OBJECTIVE: Since the last epidemiologic review of neuromyelitis optica/neuromyelitis optica spectrum disorder (NMO/NMOSD), 22 additional studies have been conducted. ...
OBJECTIVE: Since the last epidemiologic review of neuromyelitis optica/neuromyelitis optica spectrum disorder (N …
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders.
Kaegi C, Wuest B, Schreiner J, Steiner UC, Vultaggio A, Matucci A, Crowley C, Boyman O. Kaegi C, et al. Front Immunol. 2019 Sep 6;10:1990. doi: 10.3389/fimmu.2019.01990. eCollection 2019. Front Immunol. 2019. PMID: 31555262 Free PMC article.
Conclusions: Rituximab is both safe and effective for the treatment of acquired angioedema with C1-inhibitor deficiency, ANCA-associated vasculitis, autoimmune hemolytic anemia, Behcet's disease, bullous pemphigoid, Castleman's disease, cryoglobulinemia, Goodpasture's disease, Ig …
Conclusions: Rituximab is both safe and effective for the treatment of acquired angioedema with C1-inhibitor deficiency, ANCA-associated vas …
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders.
Kaegi C, Wuest B, Crowley C, Boyman O. Kaegi C, et al. Front Immunol. 2022 Feb 2;12:788830. doi: 10.3389/fimmu.2021.788830. eCollection 2021. Front Immunol. 2022. PMID: 35185862 Free PMC article.
Ublituximab was assessed in relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorder, with promising results, however, the included number of patients was too small to conclude. ...
Ublituximab was assessed in relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorder, with promising …
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.
Garred P, Tenner AJ, Mollnes TE. Garred P, et al. Pharmacol Rev. 2021 Apr;73(2):792-827. doi: 10.1124/pharmrev.120.000072. Pharmacol Rev. 2021. PMID: 33687995 Free PMC article.
Those currently being efficiently treated include paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, myasthenia gravis, and neuromyelitis optica spectrum disorders. Rare diseases, unfortunately, preclude robust clinical trials. ...
Those currently being efficiently treated include paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, myasthenia gravis …
Neuromyelitis optica.
Cree BA, Goodin DS, Hauser SL. Cree BA, et al. Semin Neurol. 2002 Jun;22(2):105-22. doi: 10.1055/s-2002-36534. Semin Neurol. 2002. PMID: 12524556 Review.
Whether neuromyelitis optica (NMO), the co-occurrence of myelitis and optic neuritis, is a variant of multiple sclerosis (MS) or a unique disease is controversial. ...
Whether neuromyelitis optica (NMO), the co-occurrence of myelitis and optic neuritis, is a variant of multiple sclerosis (MS) …
Familial neuromyelitis optica spectrum disorders: Case series and systematic review.
Wannaphut C, Ongphichetmetha T, Satiraphan P, Jitprapaikulsan J, Apiwattanakul M, Siritho S, Prayoonwiwat N, Savangned P, Rattanathamsakul N. Wannaphut C, et al. Mult Scler Relat Disord. 2023 May;73:104627. doi: 10.1016/j.msard.2023.104627. Epub 2023 Mar 21. Mult Scler Relat Disord. 2023. PMID: 37015139
BACKGROUND: Neuromyelitis optica spectrum disorders (NMOSD) is considered a complex multifactorial disorder. ...
BACKGROUND: Neuromyelitis optica spectrum disorders (NMOSD) is considered a complex multifactorial disorder. ...
Multiple Sclerosis-Minimizing Errors in Radiological Diagnosis.
Boski N, Gulati V, Raj R, Gulati P. Boski N, et al. Neurol India. 2021 Nov-Dec;69(6):1539-1546. doi: 10.4103/0028-3886.333497. Neurol India. 2021. PMID: 34979638 Free article. Review.
RESULTS: Common mimickers of MS include small vessel disease, acute disseminated encephalomyelitis, neuromyelitis optica, anti-MOG encephalomyelitis, vasculitis, and CADASIL. ...
RESULTS: Common mimickers of MS include small vessel disease, acute disseminated encephalomyelitis, neuromyelitis optica, anti …
Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review.
Musubire AK, Derdelinckx J, Reynders T, Meya DB, Bohjanen PR, Cras P, Willekens B. Musubire AK, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 18;8(6):e1089. doi: 10.1212/NXI.0000000000001089. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34663674 Free PMC article.
BACKGROUND AND OBJECTIVES: Neuromyelitis optica (NMO) is a CNS inflammatory disease that predominantly affects the optic nerves and the spinal cord. ...METHODS: A systematic review was performed in January 2021 with the search terms "Neuromyelitis optica …
BACKGROUND AND OBJECTIVES: Neuromyelitis optica (NMO) is a CNS inflammatory disease that predominantly affects the optic nerve …
Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S, Afshari-Safavi A, Vaheb S, Kiani M, Ghaffary EM, Barzegar M, Shaygannejad V, Zabeti A, Mirmosayyeb O. Bagherieh S, et al. Neurol Sci. 2023 Jun;44(6):1905-1915. doi: 10.1007/s10072-023-06617-y. Epub 2023 Feb 6. Neurol Sci. 2023. PMID: 36745300 Review.
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a progressive demyelinating disease of the central nervous system that has overlapping symptoms with multiple sclerosis (MS) but differs from it in a variety of ways. ...
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a progressive demyelinating disease of the central nervous syste …
86 results